Literature DB >> 3523209

Studies on the biological activity of an insulin-stimulating peptide from a tryptic digest of bovine serum albumin.

A Ueno, N Arakaki, T Oribe, Y Takeda.   

Abstract

A two-chain polypeptide, which corresponds to amino acid residues 115-143 and 144-184(185) of bovine serum albumin, connected to each other by a disulfide bridge, potentiated the effects of insulin on glucose transport and glucose metabolism in isolated rat adipocytes. Although the peptide alone had little activity, it shifted the concentration-response curves of insulin-stimulated D-[1-14C]glucose oxidation, 2-deoxyglucose transport, and lipid synthesis from D-[U-14C]glucose to lower insulin concentrations. It also increased the maximal responses of these parameters to insulin. However, it did not affect insulin binding to adipocytes. The peptide protected insulin considerably from degradation, but this effect alone cannot account for its effect in increasing the maximal responses to the hormone, and even when degradation of a submaximal concentration of insulin was suppressed by bacitracin, the peptide still had an enhancing effect. These results suggest not only that the peptide influences a step distal to receptor-mediated insulin binding but also that inhibition of insulin degradation alone cannot explain its total effect. The peptide lost its insulin-stimulating activity completely when it was further digested with V8 or lysine-specific endopeptidase, or when it was reduced and then carboxamidomethylated or oxidized with performic acid. Similar active tryptic fragments were obtained from human and rat albumins. Insulin-stimulating peptides should be useful in studies on the mechanisms of insulin action including both the sensitivities and responsiveness of target cells to the hormone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3523209     DOI: 10.1007/bf00229427

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

2.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

3.  Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.

Authors:  B Desbuquois; F Krug; P Cuatrecasas
Journal:  Biochim Biophys Acta       Date:  1974-03-20

4.  Insulin-stimulating peptide from tryptic digest of bovine serum albumin.

Authors:  A Ueno; N Arakaki; H Inoue; T Oribe; Y Takeda
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

5.  The minimal amino acid sequence of the insulin-potentiating fragments of human growth hormone: its mechanism of action.

Authors:  F M Ng; J Bornstein; C E Pullin; J O Bromley; S L Macaulay
Journal:  Diabetes       Date:  1980-10       Impact factor: 9.461

6.  Binding and receptor-mediated degradation of insulin in adipocytes.

Authors:  J Gliemann; O Sonne
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

7.  Internalization and degradation of fat cell-bound insulin. Separation and partial characterization of subcellular vesicles associated with iodoinsulin.

Authors:  K Suzuki; T Kono
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

8.  Potentiation of the hypoglycemic effect of insulin by thiorphan, an enkephalinase inhibitor.

Authors:  R E Chipkin; W Kreutner; W Billard
Journal:  Eur J Pharmacol       Date:  1984-06-15       Impact factor: 4.432

9.  Rapid increase in the insulin sensitivity of rat adipocytes after intravenous glucose administration.

Authors:  J N Livingston; W J Kingston; L Finocchiaro; R T Moxley
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

10.  Marked increase in insulin sensitivity of human fat cells 1 hour after glucose ingestion.

Authors:  P Arner; J Bolinder; J Ostman
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

View more
  1 in total

1.  Possible Mechanisms by Which Enzymatic Degradation of Human Serum Albumin Can Lead to Bioactive Peptides and Biomarkers.

Authors:  Ulrich Kragh-Hansen
Journal:  Front Mol Biosci       Date:  2018-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.